Prescribed and Depleted: How Common Australian Medications Are Quietly Draining Your Nutritional Reserves
For the more than two million Australians currently taking cholesterol-lowering statins, or the many hundreds of thousands relying on proton pump inhibitors (PPIs) for reflux management, there is a dimension of long-term medication use that rarely surfaces in a standard GP consultation. These drugs work — often remarkably well — at their intended purpose. But they do not work in isolation. Inside the body, they interact with metabolic pathways, digestive enzymes, and transport proteins in ways that can gradually reduce the availability of nutrients your cells depend on every day.
This phenomenon, known in clinical nutrition circles as drug-induced nutrient depletion, is not a fringe theory. It is well-documented in the pharmacological literature. What remains less well-understood — at least at the level of the average Australian consumer — is which medications are most problematic, which nutrients are most at risk, and what can realistically be done about it.
What Drug-Induced Nutrient Depletion Actually Means
To understand how this occurs, it helps to consider how medications interact with the body's biochemistry. Some drugs alter the pH environment in the digestive tract, making certain nutrients harder to absorb. Others compete with vitamins or minerals for the same transport mechanisms. Some accelerate the metabolic breakdown of specific nutrients, effectively increasing the body's demand for them. And others interfere with the enzymes responsible for converting nutrient precursors into their active, usable forms.
The result, in many cases, is not an immediate or dramatic deficiency. The depletion tends to be gradual, occurring over months or years of continuous use. By the time symptoms appear — fatigue, muscle weakness, cognitive fog, peripheral tingling — they are often attributed to ageing, stress, or the underlying condition being treated, rather than to the medication itself.
The Statin and CoQ10 Connection
Perhaps the most widely discussed example of drug-induced nutrient depletion involves statins and coenzyme Q10, commonly referred to as CoQ10 or ubiquinone. Statins — including atorvastatin, rosuvastatin, and simvastatin, all of which appear on Australia's Pharmaceutical Benefits Scheme — work by inhibiting an enzyme called HMG-CoA reductase, which is responsible for cholesterol synthesis in the liver. What is less frequently explained to patients is that this same biochemical pathway also produces CoQ10.
CoQ10 is not a minor nutrient. It plays a central role in mitochondrial energy production, acting essentially as a cellular fuel converter. It also functions as a potent antioxidant. Reduced CoQ10 availability has been associated with the muscle-related side effects — aching, weakness, and in rare cases more serious myopathy — that some statin users experience. The irony is significant: a drug prescribed to protect cardiovascular health may, over time, compromise the energy metabolism of the very heart muscle it is meant to benefit.
While Australian prescribers are not obligated to discuss CoQ10 supplementation alongside statin prescriptions, many integrative health practitioners and some cardiologists now routinely recommend it for patients on long-term statin therapy.
Proton Pump Inhibitors and the B12 Problem
Proton pump inhibitors such as omeprazole, esomeprazole, and pantoprazole are among the most frequently dispensed medications in Australia. They are effective at reducing stomach acid, providing relief for conditions ranging from gastro-oesophageal reflux disease to peptic ulcers. However, stomach acid is not merely a source of discomfort — it is an essential component of the process by which vitamin B12 is released from food and made available for absorption.
Without adequate stomach acid, B12 absorption is significantly impaired. Over years of PPI use, this can translate into a genuine B12 deficiency, which carries serious consequences: nerve damage, memory difficulties, fatigue, and in advanced cases, irreversible neurological harm. Older Australians, who are both more likely to be prescribed PPIs long-term and more likely to have reduced B12 absorption to begin with, face a compounded risk.
Beyond B12, PPIs have also been associated with reduced absorption of magnesium, calcium, and iron — each of which carries its own set of implications for bone density, cardiovascular function, and energy levels.
Other Medications Worth Knowing About
The statin and PPI examples are the most prominent, but they are far from the only ones. Consider the following:
Metformin, widely prescribed for type 2 diabetes management in Australia, has a well-established association with reduced vitamin B12 absorption. Australian endocrinology guidelines now acknowledge this, yet routine B12 monitoring for metformin users remains inconsistent across general practice.
Oral contraceptives have been linked to reductions in folate, B6, B12, magnesium, zinc, and selenium. Given how long many Australian women use hormonal contraception, the cumulative nutritional impact deserves more attention than it typically receives.
Diuretics, commonly prescribed for hypertension and heart failure, accelerate the urinary excretion of potassium, magnesium, and zinc. Potassium depletion in particular carries cardiac risks, yet routine supplementation advice is not always provided alongside a diuretic prescription.
Corticosteroids such as prednisolone, used for inflammatory and autoimmune conditions, interfere with calcium absorption and accelerate bone loss, increasing the risk of osteoporosis — a concern particularly relevant for post-menopausal Australian women already at elevated risk.
Why Australian GPs Rarely Raise It
The reasons this topic does not routinely surface in GP consultations are largely structural rather than negligent. General practice appointments in Australia operate under considerable time pressure. A standard consultation is allocated a fixed Medicare item number that rewards efficiency. When a patient presents with a chronic condition requiring ongoing medication management, the priority is typically monitoring the condition, adjusting dosages, and addressing immediate symptoms — not conducting a nutritional audit.
Furthermore, the evidence base for drug-induced nutrient depletion, while substantial, is not yet uniformly integrated into Australian prescribing guidelines. This means there is no formal prompt reminding a GP to discuss CoQ10 when initiating statin therapy, or to monitor B12 annually in a long-term PPI user.
This is not a criticism of Australian general practitioners. It is an observation about a gap in the system — one that informed patients can, to some extent, bridge themselves.
Practical Steps for Australians on Long-Term Medications
If you are taking any of the medications discussed above — or any other long-term prescription — there are several reasonable steps worth considering:
Request relevant blood tests. Ask your GP whether your medication has any known associations with nutrient depletion and whether monitoring specific levels (such as B12, magnesium, or vitamin D) would be appropriate given your treatment history.
Review your supplement use with a professional. Not all supplements are appropriate for all people, and some can interact with medications in their own right. A consultation with a pharmacist or accredited practising dietitian can help identify where targeted supplementation may be warranted.
Prioritise dietary diversity. While supplementation has its place, a nutrient-dense diet remains the most reliable foundation. Leafy greens, legumes, wholegrains, lean protein, and fermented foods each contribute meaningfully to the nutrient reserves that long-term medications may be quietly drawing down.
Keep a complete medication and supplement list. When visiting any healthcare provider, presenting a current list of everything you take — prescribed, over-the-counter, and supplementary — enables a more informed conversation about potential interactions and nutritional gaps.
Don't discontinue prescribed medications without guidance. It bears emphasising that the appropriate response to drug-induced nutrient depletion is not to stop taking a necessary medication. The risks of untreated high cholesterol, uncontrolled diabetes, or severe reflux disease are real. The goal is to manage both the condition and its nutritional consequences concurrently.
The Bigger Picture
Australia's pharmaceutical system is among the most effective in the world at ensuring access to evidence-based medications. What it is less equipped to deliver — at least within the constraints of a standard consultation — is a comprehensive view of how those medications interact with the body's nutritional ecosystem over time. That gap belongs to all of us to fill: through informed conversations with healthcare providers, through proactive monitoring, and through a genuine understanding that taking a medicine is rarely a simple, isolated act. It is a long-term biochemical negotiation — and the more informed you are, the better positioned you are to navigate it.
